Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring

. 2020 Jan ; 115 (1) : 109-120. [epub] 20191023

Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid31642141

Grantová podpora
COST Action ES1307 European Cooperation in Science and Technology - International
163049-051 The Icelandic Research Fund - International
Thyne Reid Foundation - International
CTM2017-84763-C3-2-R MINECO/AEI - International
317205 EU International Training Network SEWPROF - International
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) - International
ED481D 2017/003 Galician Council of Culture, Education and Universities - International
Marie Curie-FP7-PEOPLE EU International Training Network SEWPROF - International
Environmental Sustainability Knowledge Transfer Network, Engineering and Physical Sciences Research Council and Thermo Fisher Scientific - International
Natural Sciences and Engineering Research Council of Canada (NSERC) - International
MR/S019669/1 Medical Research Council - United Kingdom
CTM2016-81935-REDT MINECO/AEI - International
CTM2014-56628-C3-2-R MINECO/AEI - International
CTQ2015-65603-P MINECO/AEI - International
L1-9191 Slovene Research Agency - International
HOME/2015/ISFP/PR/DRUG/0062 Wastewater Analysis of Traces of illicit drug-related Chemicals for law enforcement and public Health (WATCH) - International

BACKGROUND AND AIMS: Wastewater-based epidemiology is an additional indicator of drug use that is gaining reliability to complement the current established panel of indicators. The aims of this study were to: (i) assess spatial and temporal trends of population-normalized mass loads of benzoylecgonine, amphetamine, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in raw wastewater over 7 years (2011-17); (ii) address overall drug use by estimating the average number of combined doses consumed per day in each city; and (iii) compare these with existing prevalence and seizure data. DESIGN: Analysis of daily raw wastewater composite samples collected over 1 week per year from 2011 to 2017. SETTING AND PARTICIPANTS: Catchment areas of 143 wastewater treatment plants in 120 cities in 37 countries. MEASUREMENTS: Parent substances (amphetamine, methamphetamine and MDMA) and the metabolites of cocaine (benzoylecgonine) and of Δ9 -tetrahydrocannabinol (11-nor-9-carboxy-Δ9 -tetrahydrocannabinol) were measured in wastewater using liquid chromatography-tandem mass spectrometry. Daily mass loads (mg/day) were normalized to catchment population (mg/1000 people/day) and converted to the number of combined doses consumed per day. Spatial differences were assessed world-wide, and temporal trends were discerned at European level by comparing 2011-13 drug loads versus 2014-17 loads. FINDINGS: Benzoylecgonine was the stimulant metabolite detected at higher loads in southern and western Europe, and amphetamine, MDMA and methamphetamine in East and North-Central Europe. In other continents, methamphetamine showed the highest levels in the United States and Australia and benzoylecgonine in South America. During the reporting period, benzoylecgonine loads increased in general across Europe, amphetamine and methamphetamine levels fluctuated and MDMA underwent an intermittent upsurge. CONCLUSIONS: The analysis of wastewater to quantify drug loads provides near real-time drug use estimates that globally correspond to prevalence and seizure data.

Chair of Urban Water Management Technische Universität Dresden Dresden Germany

Department of Analytical Chemistry Complutense University of Madrid Madrid Spain

Department of Analytical Environmental and Forensic Sciences King's College London London UK

Department of Aquatic Sciences and Assessment Swedish University of Agricultural Sciences Uppsala Sweden

Department of Chemical Engineering McGill University Montreal Quebec Canada

Department of Chemical Engineering University of Bath Bath UK

Department of Chemistry Laboratory of Analytical Chemistry National and Kapodistrian University of Athens Athens Greece

Department of Chemistry University of Bath Bath UK

Department of Coal Chemistry and Environmental Sciences AGH University of Science and Technology Krakow Poland

Department of Environmental Engineering Faculty of Chemical and Food Technology Slovak University of Technology Bratislava Slovakia

Department of Environmental Engineering Technical University of Denmark Kongens Lyngby Denmark

Department of Environmental Sciences Jožef Stefan Institute Ljubljana Slovenia

Department of Pharmaceutical Sciences Toxicological Center Antwerp Belgium

Department of Pharmacology and Toxicology University of Iceland Reykjavík Iceland

Division for Marine and Environmental Research Rudjer Boskovic Institute Zagreb Croatia

Eawag Urban Water Management Swiss Federal Institute of Aquatic Science and Technology Dübendorf Switzerland

Ecole des Sciences Criminelles University of Lausanne Lausanne Switzerland

Environmental Pollution Control Laboratory Chemistry Department Aristotle University of Thessaloniki Thessaloniki Greece

Faculty of Chemical Sciences Department of Analytical Chemistry Nutrition and Bromatology University of Salamanca Salamanca Spain

Faculty of Fisheries and Protection of Waters University of South Bohemia in Ceske Budejovice Zatisi Czech Republic

Faculty of Pharmacy University of Lisbon Lisbon Portugal

Faculty of Technical Sciences Department of Environmental Engineering and Occupational Safety University of Novi Sad Novi Sad Serbia

Food and Environmental Safety Research Group University of Valencia Moncada Spain

Forensic Toxicology National Institute for Health and Welfare Helsinki Finland

IBED University of Amsterdam Amsterdam the Netherlands

Institute for Food Analysis and Research Department of Analytical Chemistry Universidade de Santiago de Compostela Santiago de Compostela Spain

Institute of Clinical Pharmacology Technische Universität Dresden Dresden Germany

Institute of Forensic Research Krakow Poland

Institute of Legal Medicine and Core Facility Metabolomics Medical University of Innsbruck Innsbruck Austria

Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy

King's Forensics School of Population Health and Environmental Sciences King's College London London UK

KWR Water Research Institute Nieuwegein the Netherlands

National Institute of Legal Medicine and Forensic Sciences Lisbon Portugal

NIREAS International Water Research Center Department of Civil and Environmental Engineering University of Cyprus Nicosia Cyprus

Norwegian Institute for Water Research Oslo Norway

Process and Systems Engineering Center Department of Chemical and Biochemical Engineering Technical University of Denmark Kongens Lyngby Denmark

Queensland Alliance for Environmental Health Sciences The University of Queensland Woolloongabba QLD Australia

Research Institute for Pesticides and Water University Jaume 1 Castellón Spain

School of Pharmacy and Medical Sciences University of South Australia Adelaide South Australia Australia

Unit of Environmental Engineering Ben Gurion University of the Negev Beer Sheva Israel

Université Paris Sud CNRS AgroParisTech Université Paris Saclay Chatenay Malabry France

University of Bern Institute of Plant Sciences Bern Switzerland

University of Puget Sound Tacoma WA USA

Water and Soil Quality Research Group Department of Environmental Chemistry Institute of Environmental Assessment and Water Research Barcelona Spain

Erratum v

PubMed

Zobrazit více v PubMed

United Nations Office on Drugs and Crime (UNODC) . World Drug Report. ISBN: 978‐92‐1‐148291‐1, eISBN: 978‐92‐1‐060623‐3, United Nations publication, Sales no. E17XI6. Vienna, Austria: UNODC; 2017.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) . European Drug Report 2017: Trends and Developments. Luxembourg: Publications Office of the European Union; 2017.

Degenhardt L., Whiteford H. A., Ferrari A. J., Baxter A. J., Charlson F. J., Hall W. D., et al Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study 2010. Lancet 2013; 382: 1564–1574. PubMed

World Health Organization . Management of Substance Abuse, Facts and Figures. Available at: http://www.who.int/substance_abuse/facts/global_burden/en/ (Archived at: http://www.webcitation.org/719Jsw9mJ on 24/07/2018).

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) . Available at: http://www.emcdda.europa.eu/activities/wastewater-analysis (Archived at: http://www.webcitation.org/74bvBmO9c on 12/12/2018).

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) . Common Protocol of Action for Monitoring Illicit Drugs in Wastewater. Available at: https://goo.gl/seR7Ke.

Sewage Analysis Core Group Europe (SCORE) . Available at: http://score-cost.eu/ (Archived at http://www.webcitation.org/719LxOduL%20on%2024/07/2018).

Thomas K. V., Bijlsma L., Castiglioni S., Covaci A., Emke E., Grabic R., et al Comparing illicit drug use in 19 European cities through sewage analysis. Sci Total Environ 2012; 432: 432–439. PubMed

Ort C., van Nuijs A. L. N., Berset J. D., Bijlsma L., Castiglioni S., Covaci A., et al Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis. Addiction 2014; 109: 1338–1352. PubMed PMC

Causanilles A., Baz‐Lomba J. A., Burgard D. A., Emke E., González‐Mariño I., Krizman‐Matasic I., et al Improving wastewater‐based epidemiology to estimate cannabis use: focus on the initial aspects of the analytical procedure. Anal Chim Acta 2017; 988: 27–33. PubMed

Bijlsma L., Beltrán E., Boix C., Sancho J. V., Hernández F. Improvements in analytical methodology for the determination of frequently consumed illicit drugs in urban wastewater. Anal Bioanal Chem 2014; 406: 4261–4272. PubMed

Hernández F., Castiglioni S., Covaci A., de Voogt P., Emke E., Kasprzyk‐Hordern B., et al Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater. Mass Spectrom Rev 2018; 37: 258–280. PubMed PMC

Ort C., Alygizakis N. A., Andrés‐Costa M., Bade R., Bannwarth A., Banta‐Green C. et al Dataset: Illicit drugs in Wastewater—SCORE Initiative. Version 1.0 [Data files]; 2019. Available at: 10.25678/000172, accessed on 11/09/2019 DOI

R Core Team R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2015.

Castiglioni S., Bijlsma L., Covaci A., Emke E., Hernández F., Reid M., et al Evaluation of uncertainties associated with the determination of community drug use through the measurement of sewage drug biomarkers. Environ Sci Tech 2013; 47: 1452–1460. PubMed

Gracia‐Lor E., Zuccato E., Castiglioni S. Refining correction factors for back‐calculation of illicit drug use. Sci Total Environ 2016; 573: 1648–1659. PubMed

Zuccato E., Chiabrando C., Castiglioni S., Bagnati R., Fanelli R. Estimating community drug abuse by wastewater analysis. Environ Health Perspect 2008; 116: 1027–1032. PubMed PMC

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) . Drug Profiles. Available at: http://www.emcdda.europa.eu/drug-profiles (Archived at: http://www.webcitation.org/73dJQl1ua on 2/11/2018).

van Nuijs A. L. N., Lai F. Y., Been F., Andrés‐Costa M. J., Barron L., Baz‐Lomba J. A., et al Multi‐year interlaboratory exercises for the analysis of illicit drugs and metabolites in wastewater: development of a quality control system. Trends Anal Chem 2018; 103: 34–43.

Sewage Analysis Core Group Europe (SCORE) . Network Activities. Interlab. Available at: http://score-cost.eu/monitoring/interlab/ (Archived at: http://www.webcitation.org/719MR2c4i%20on%2024/07/2018).

McCall A. K., Bade R., Kinyua J., Lai F. Y., Thai P. K., Covaci A., et al Critical review on the stability of illicit drugs in sewers and wastewater samples. Water Res 2016; 88: 933–947. PubMed

van Nuijs A. L. N., Pecceu B., Theunis L., Dubois N., Charlier C., Jorens P. G., et al Cocaine and metabolites in waste and surface water across Belgium. Environ Pollut 2009; 157: 123–129. PubMed

Nefau T., Karolak S., Castillo L., Boireau V., Levi Y. Presence of illicit drugs and metabolites in influents and effluents of 25 sewage water treatment plants and map of drug consumption in France. Sci Total Environ 2014; 487: 696–702. PubMed

Zuccato E., Castiglioni S., Senta I., Borsotti A., Genetti B., Andreotti A., et al Population surveys compared with wastewater analysis for monitoring illicit drug consumption in Italy in 2010–2014. Drug Alcohol Depend 2016; 161: 178–188. PubMed

Been F., Bijlsma L., Benaglia L., Berset J. D., Botero‐Coy A. M., Castiglioni S., et al Assessing geographical differences in illicit drug consumption—a comparison of results from epidemiological and wastewater data in Germany and Switzerland. Drug Alcohol Depend 2016; 161: 189–199. PubMed

Kankaanpää A., Ariniemi K., Heinonen M., Kuoppasalmi K., Gunnar T. Current trends in Finnish drug abuse: wastewater‐based epidemiology combined with other national indicators. Sci Total Environ 2016; 568: 864–874. PubMed

Emke E., Evans S., Kasprzyk‐Hordern B., de Voogt P. Enantiomer profiling of high loads of amphetamine and MDMA in communal sewage: a Dutch perspective. Sci Total Environ 2014; 487: 666–672. PubMed

Emke E., Vughs D., Kolkman A., de Voogt P. Wastewater‐based epidemiology generated forensic information: amphetamine synthesis waste and its impact on a small sewage treatment plant. Forensic Sci Int 2018; 286: e1–e7. PubMed

Löve A. S. C., Baz‐Lomba J. A., Reid M. J., Kankaanpää A., Gunnar T., Dam M., et al Analysis of stimulant drugs in the wastewater of five Nordic capitals. Sci Total Environ 2018; 627: 1039–1047. PubMed

Khan U., Nicell J. A. Sewer epidemiology mass balances for assessing the illicit use of methamphetamine, amphetamine and tetrahydrocannabinol. Sci Total Environ 2012; 421‐422: 144–162. PubMed

Heal D. J., Smith S. L., Gosden J., Nutt D. J. Amphetamine: past and present—a pharmacological and clinical perspective. J Psychopharmacol 2013; 27: 479–496. PubMed PMC

Lai F. Y., O'Brien J., Bruno R., Hall W., Prichard J., Kirkbride P., et al Spatial variations in the consumption of illicit stimulant drugs across Australia: a nationwide application of wastewater‐based epidemiology. Sci Total Environ 2016; 568: 810–818. PubMed

Jalal H., Buchanich J. M., Roberts M. S., Balmert L. C., Zhang K., Burke D. S. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science 2018; 361: eaau1184. PubMed PMC

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) . European Drug Report 2018: Trends and Developments. Luxembourg: Publications Office of the European Union; 2018.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) . EU Drug Markets Report: In‐Depth Analysis. EMCDDA–Europol joint publications. Luxembourg: Publications Office of the European Union; 2016.

Cody J. T. Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results. J Occup Environ Med 2002; 44: 435–450. PubMed

Xu Z., Du P., Li K., Gao T., Wang Z., Fu X., et al Tracing methamphetamine and amphetamine sources in wastewater and receiving waters via concentration and enantiomeric profiling. Sci Total Environ 2017; 601–602: 159–166. PubMed

Castrignanò E., Yang Z., Bade R., Baz‐Lomba J. A., Castiglioni S., Causanilles A., et al Enantiomeric profiling of chiral illicit drugs in a pan‐European study. Water Res 2018; 130: 151–160. PubMed

Kasprzyk‐Hordern B., Baker D. R. Estimation of community‐wide drugs use via stereoselective profiling of sewage. Sci Total Environ 2012; 423: 142–150. PubMed

Gao J., Xu Z., Li X., O'Brien J. W., Culshaw P. N., Thomas K. V., et al Enantiomeric profiling of amphetamine and methamphetamine in wastewater: a 7‐year study in regional and urban Queensland, Australia. Sci Total Environ 2018; 643: 827–834. PubMed

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) . Statistical Bulletin 2017—seizures of drugs. Available at: http://www.emcdda.europa.eu/data/stats2017/szr_en (Archived at: http://www.webcitation.org/71tQEv8KT on 23/08/2018).

Mounteney J., Griffiths P., Bo A., Cunningham A., Matias J., Pirona A. Nine reasons why ecstasy is not quite what it used to be. Int J Drug Policy 2018; 51: 36–41. PubMed

Netherlands Institute of Mental Health and Addiction . Drugs Informatie en Monitoring Systeem, Jaarbericht; 2016. Available at: https://assets.trimbos.nl/docs/bb499f0e-177e-454d-888e-f22508e45f38.pdf, accesed on 11/09/2019

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...